Effect of combined treatment with cyclophosphamidum and allicin on neuroblastoma–bearing mice
Xiangyang Gao(South China Agricultural University), Guangjun Hou(Zhengzhou Children's Hospital), Wenlong Zhai(Zhengzhou University), Wei Yuan(Shanghai Public Health Clinical Center), Xianwei Zhang(Tongji Hospital)
Cited by 27
Related Papers
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer
|Molecular Cancer|2022|652
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial
|The Lancet Oncology|2019|649
Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer
|European Urology|2019|464
Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition
|Cancer Discovery|2017|422